Vimarsana
Biggest News Aggregation in the World

Page 8 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oint Inflammation Today - Breaking & Trending Today

Bimekizumab Promising for Palmoplantar Pustular Psoriasis - Vimarsana News

Bimekizumab Promising for Palmoplantar Pustular Psoriasis

PPP is a type of pustular psoriasis that remains a treatment challenge, and available treatments for palmoplantar plaque psoriasis with pustules also "remain unsatisfactory."

Exploring the genetic links: Alcohol, smoking, coffee intake, and arthritis risk - Vimarsana News

Exploring the genetic links: Alcohol, smoking, coffee intake, and arthritis risk

The genetic relationship between alcohol consumption, smoking, coffee intake, and the risk of arthritis.

DMARDs Linked to Reduced Thyroid Disease Incidence - Vimarsana News

DMARDs Linked to Reduced Thyroid Disease Incidence

In a large Swedish rheumatoid arthritis cohort, the incidence of thyroid disease declines after RA diagnosis vs the general population, with the effect strongest among those treated with anti-rheumatic drugs.

At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib - Vimarsana News

At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib

With response curves still climbing at follow-up to date, the results are 'truly, truly remarkable.'

Telitacicept Shows Efficacy, Safety in MTX-Resistant RA - Vimarsana News

Telitacicept Shows Efficacy, Safety in MTX-Resistant RA

Telitacicept is a recombinant fusion protein that aims to target and neutralize B lymphocyte stimulator and a proliferation-inducing ligand (APRIL), both of which are linked to autoimmunity.